Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Cipla And NiPPharma In Respiratory Device Deal?

This article was originally published in PharmAsia News

Executive Summary

Cipla Ltd. is speculated to have struck a deal with Japan's NiPPharma Co., Ltd for a device apparently meant for the Indian firm's generic Advair dry powder inhaler, but some analysts suggest that limited visibility around the trials of the firm's combination product in the US are the main concern for now.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register